48,836
edits
Difference between revisions of "Sertoli cell tumour"
Jump to navigation
Jump to search
Sertoli cell tumour (view source)
Revision as of 10:36, 13 September 2023
, 10:36, 13 September 2023→IHC
m (touch) |
(→IHC) |
||
| Line 69: | Line 69: | ||
*Alpha-inhibin +ve (~95% of cases<ref name=pmid17721194/>). | *Alpha-inhibin +ve (~95% of cases<ref name=pmid17721194/>). | ||
*Calretiin +ve (~55% of cases<ref name=pmid17721194/>). | *Calretiin +ve (~55% of cases<ref name=pmid17721194/>). | ||
*Beta-catenin (nuclear +ve).<ref>{{cite journal |authors=Zhang C, Ulbright TM |title=Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord-Stromal Tumors of the Testis: An Immunohistochemical Study of 87 Cases |journal=Am J Surg Pathol |volume=39 |issue=10 |pages=1390–4 |date=October 2015 |pmid=26034868 |doi=10.1097/PAS.0000000000000455 |url=}}</ref> | |||
Others: | Others: | ||